Atlas Trials

Combination of Daratumumab and BD Regimen and Dapagliflozin in the Treatment of M-protein Related Cardiac Disease

Clinical trial NCT06297681 · UNKNOWN

Trial details

NCT number
NCT06297681
Sponsor
Beijing Chao Yang Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
M-protein Related Cardiac Disease
Start date
2024-03-15
Primary completion
2025-01-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.